Evidence map›Paper›PMID 37313165›Full record

ArticleHeliyon2023

Toxicological safety assessment of HempChoice® hemp oil extract; a proprietary extract consisting of a high concentration of cannabidiol (CBD) in addition to other phytocannabinoids and terpenes derived from

Margitta Dziwenka, Robert Coppock, Michael H Davidson, Marc A Weder

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Genotoxicity study ofToxicology reports · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Margitta DziwenkaGRAS Associates Nutrasource Pharmaceutical and Nutraceutical Services, 120 Research Lane, Suite 101, Guelph, Ontario, Canada, N1G 0B4.
Robert CoppockToxicologist and Associates Ltd., PO Box 2031, Vegreville, AB T9C 1T2, Canada.
Michael H DavidsonGeocann, Innovation, Technology, & Clinical Research Dept., 320 E Vine Drive, Suite 207, Fort Collins, CO, 80524, USA.
Marc A WederVesifact AG, Joechlerweg 4, 6340, Baar, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HempChoice® Hemp Oil Extract (Geocann, LLC) is an extract of the aerial parts of hemp (

Indexed as

CannabidiolCannabis sativaGeocannHemp extractMutagenicityToxicity

Identifiers

PMID37313165
PMCPMC10258502

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.